Researcher
Gert De Meerleer
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Member
From1 Oct 2016 → Today
Projects
1 - 4 of 4
- Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE)From24 Sep 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Metastasis-directed therapy in castration-refractory prostate cancer: MEDCAREFrom1 Jan 2019 → 31 Dec 2022Funding: Foundations, funds and other with scientific goal
- Novel insights in the definition and treatment of high risk and oligometastatic prostate cancerFrom1 Oct 2018 → 18 Nov 2022Funding: FWO fellowships
- Traveling the prostate cancer timeline in chase of treatment paradigms Can we cure the incurable?From1 Aug 2017 → 1 Oct 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
71 - 80 of 117
- Have We Entered the Era of Imaging Before Salvage Treatment for Recurrent Prostate Cancer?(2019)
Authors: Gaëtan Devos, Gert De Meerleer, Steven Joniau
Pages: 265 - 267 - Metastasectomy for visceral and skeletal oligorecurrent prostate cancer(2019)
Authors: Gaëtan Devos, Lisa Moris, Charlien Berghen, Wouter Everaerts, Maarten Albersen, Gert De Meerleer, Hendrik Van Poppel, Karolien Goffin, Steven Joniau
Pages: 1543 - 1549 - Impact of Magnetic Resonance Imaging on Prostate Cancer Staging and European Association of Urology Risk Classification(2019)
Authors: Cédric Draulans, Wouter Everaerts, Sofie Isebaert, Thomas Gevaert, Raymond Oyen, Steven Joniau, Birgit Weynand, Gert De Meerleer, Karin Haustermans
Pages: 113 - 119 - Extended field radiotherapy measurements in a single shot using a BaFBr-based OSL-film(2019)
Authors: Robin De Roover, Charlien Berghen, Gert De Meerleer, Tom Depuydt, Wouter Crijns
- Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial(2019)
Authors: Elke Rammant, Piet Ost, Martijn Swimberghe, Barbara Vanderstraeten, Nicolaas Lumen, Karel Decaestecker, Renee Bultijnck, Gert De Meerleer, Camille Sarrazyn, Roos Colman, et al.
Pages: 393 - 401 - Metastasis-directed therapy for oligoprogressive castration refractory prostate cancer(2019)
Authors: C Berghen, S Joniau, P Ost, K Poels, W Everaerts, K Haustermans, Gert De Meerleer
Pages: S451 - S451 - Nine-year survival after iterative metastasectomies for renal cell carcinoma(2019)
Authors: Wouter Everaerts, Gert De Meerleer, Steven Joniau
Pages: 219 - 221 - What Is Oligometastatic Prostate Cancer?(2019)
Authors: Gert De Meerleer
Pages: 159 - 161 - Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review(2019)
Authors: Gert De Meerleer, Lisa Moris, Gaëtan Devos, Wouter Everaerts, Steven Joniau
Pages: 174 - 188 - Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (vol 50, pg 928, 2018)(2019)
Authors: Fredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, Sara Benlloch, Mahbubl Ahmed, Edward J Saunders, Tokhir Dadaev, Daniel Leongamornlert, Ezequiel Anokian, Clara Cieza-Borrella, et al.
Pages: 363 - 363